PT Merck Tbk Statistics
Total Valuation
PT Merck Tbk has a market cap or net worth of IDR 1.53 trillion. The enterprise value is 1.47 trillion.
Market Cap | 1.53T |
Enterprise Value | 1.47T |
Important Dates
The next estimated earnings date is Wednesday, April 30, 2025.
Earnings Date | Apr 30, 2025 |
Ex-Dividend Date | Jun 7, 2024 |
Share Statistics
PT Merck Tbk has 448.00 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 448.00M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 59.81M |
Valuation Ratios
The trailing PE ratio is 9.94.
PE Ratio | 9.94 |
Forward PE | n/a |
PS Ratio | 1.47 |
PB Ratio | 1.88 |
P/TBV Ratio | 1.90 |
P/FCF Ratio | 38.81 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.59, with an EV/FCF ratio of 37.33.
EV / Earnings | 9.58 |
EV / Sales | 1.42 |
EV / EBITDA | 6.59 |
EV / EBIT | 7.58 |
EV / FCF | 37.33 |
Financial Position
The company has a current ratio of 6.52, with a Debt / Equity ratio of 0.03.
Current Ratio | 6.52 |
Quick Ratio | 2.85 |
Debt / Equity | 0.03 |
Debt / EBITDA | 0.09 |
Debt / FCF | 0.51 |
Interest Coverage | 42.75 |
Financial Efficiency
Return on equity (ROE) is 19.15% and return on invested capital (ROIC) is 14.77%.
Return on Equity (ROE) | 19.15% |
Return on Assets (ROA) | 12.66% |
Return on Invested Capital (ROIC) | 14.77% |
Return on Capital Employed (ROCE) | 22.87% |
Revenue Per Employee | 2.76B |
Profits Per Employee | 408.15M |
Employee Count | 372 |
Asset Turnover | 1.08 |
Inventory Turnover | 1.65 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.59% in the last 52 weeks. The beta is 0.47, so PT Merck Tbk's price volatility has been lower than the market average.
Beta (5Y) | 0.47 |
52-Week Price Change | -15.59% |
50-Day Moving Average | 3,424.60 |
200-Day Moving Average | 3,664.80 |
Relative Strength Index (RSI) | 55.35 |
Average Volume (20 Days) | 8,920 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Merck Tbk had revenue of IDR 1.04 trillion and earned 153.46 billion in profits. Earnings per share was 343.00.
Revenue | 1.04T |
Gross Profit | 402.67B |
Operating Income | 193.91B |
Pretax Income | 195.06B |
Net Income | 153.46B |
EBITDA | 223.09B |
EBIT | 193.91B |
Earnings Per Share (EPS) | 343.00 |
Balance Sheet
The company has 87.68 billion in cash and 20.21 billion in debt, giving a net cash position of 67.47 billion or 150.61 per share.
Cash & Cash Equivalents | 87.68B |
Total Debt | 20.21B |
Net Cash | 67.47B |
Net Cash Per Share | 150.61 |
Equity (Book Value) | 807.27B |
Book Value Per Share | 1,811.41 |
Working Capital | 600.71B |
Cash Flow
In the last 12 months, operating cash flow was 55.71 billion and capital expenditures -16.35 billion, giving a free cash flow of 39.36 billion.
Operating Cash Flow | 55.71B |
Capital Expenditures | -16.35B |
Free Cash Flow | 39.36B |
FCF Per Share | 87.86 |
Margins
Gross margin is 38.84%, with operating and profit margins of 18.70% and 14.80%.
Gross Margin | 38.84% |
Operating Margin | 18.70% |
Pretax Margin | 18.82% |
Profit Margin | 14.80% |
EBITDA Margin | 21.52% |
EBIT Margin | 18.70% |
FCF Margin | 3.80% |
Dividends & Yields
This stock pays an annual dividend of 320.00, which amounts to a dividend yield of 9.38%.
Dividend Per Share | 320.00 |
Dividend Yield | 9.38% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 93.12% |
Buyback Yield | n/a |
Shareholder Yield | 9.38% |
Earnings Yield | 10.05% |
FCF Yield | 2.58% |
Stock Splits
The last stock split was on December 21, 2015. It was a forward split with a ratio of 20.
Last Split Date | Dec 21, 2015 |
Split Type | Forward |
Split Ratio | 20 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |